Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
The fund gained 4.59% in Q4, driven by secular AI tailwinds in Taiwan and Korea, and maintains a constructive EM outlook backed by quality focus and monetary easing.
Full Quick Take
The fund gained 4.59% in Q4, driven by secular AI tailwinds in Taiwan and Korea, and maintains a constructive EM outlook backed by quality focus and monetary easing.
Gramercy Emerging Markets Debt Fund capitalized on the Fed's pivotal 25 bps rate cut through an active duration overweight and key sovereign bond outperformance in Brazil and South Africa.
Full Quick Take
Gramercy Emerging Markets Debt Fund capitalized on the Fed's pivotal 25 bps rate cut through an active duration overweight and key sovereign bond outperformance in Brazil and South Africa.
Mondrian's International Equity Value Opportunities Strategy delivered 3.9% net in Q3 2025, underperforming its benchmark due to defensive overweights and financials underweights, but remains ahead year-to-date.
Full Quick Take
Mondrian's International Equity Value Opportunities Strategy delivered 3.9% net in Q3 2025, underperforming its benchmark due to defensive overweights and financials underweights, but remains ahead year-to-date.
The Chautauqua Funds underperformed their benchmarks in Q3 2025 due to weak stock selection in Tech and Financials, leading managers to rotate capital from trimmed giants like Alphabet and Mastercard into high-conviction holdings like Novo Nordisk and Genmab.
Full Quick Take
The Chautauqua Funds underperformed their benchmarks in Q3 2025 due to weak stock selection in Tech and Financials, leading managers to rotate capital from trimmed giants like Alphabet and Mastercard into high-conviction holdings like Novo Nordisk and Genmab.
The Merchant West SCI Enhanced Income Fund outperformed its benchmark in Q3 2025 with a 3.80% return, benefiting from strong local bond inflows and disciplined duration and inflation-linked asset management.
Full Quick Take
The Merchant West SCI Enhanced Income Fund outperformed its benchmark in Q3 2025 with a 3.80% return, benefiting from strong local bond inflows and disciplined duration and inflation-linked asset management.
